Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tensarc Limited is currently overseeing 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This single action is assigned to 1 distinct examiner, which centralizes the company's current dialogue with the patent office. Furthermore, the portfolio is active within 1 distinct art unit, indicating a focused administrative presence. This structure avoids the complexity of managing multiple examiners or different art unit standards.
The busiest examiner for this portfolio is MARCHEWKA, MATTHEW R, who is responsible for 1 pending office action. Given that the total number of pending actions is 1, this examiner is managing the entirety of the company's current active prosecution. This direct relationship allows the applicant to focus their legal strategy on the specific tendencies of MARCHEWKA, MATTHEW R. The alignment of 1 pending action with 1 examiner and 1 art unit suggests a streamlined path for the company's intellectual property development. Practitioners should prioritize understanding the specific examination style of this examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARCHEWKA, MATTHEW R | 1 | 47.6% | +66.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17914870 | A FACE-GAITER SOURCE CONTROL MASK | MARCHEWKA, MATTHEW R | 113d overdue |
| Art Unit | Apps |
|---|---|
| 3732 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17914870 | A FACE-GAITER SOURCE CONTROL MASK | MARCHEWKA, MATTHEW R | 3732 | §112 | Final Rejection | 113d overdue | Pending | Sep 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTensarc Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Matthew R Marchewka has the most, with 1 of Tensarc Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.